Citation: Tianxu Zhang, Dexuan Xiao, Mi Zhou, Yunfeng Lin, Tao Zhang, Xiaoxiao Cai. Protective effect of osteogenic growth peptide functionalized tetrahedral DNA nanostructure on bone marrow and bone formation ability in chemotherapy-induced myelosuppressive mice[J]. Chinese Chemical Letters, ;2025, 36(8): 110594. doi: 10.1016/j.cclet.2024.110594 shu

Protective effect of osteogenic growth peptide functionalized tetrahedral DNA nanostructure on bone marrow and bone formation ability in chemotherapy-induced myelosuppressive mice

Tianxu Zhang ^{a, b} ,
Dexuan Xiao ^a ,
Mi Zhou ^a ,
Yunfeng Lin ^{a, c, d} ,
Tao Zhang ^{a, b, *,} ,
Xiaoxiao Cai ^{a, c, *,}

a.
State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
b.
Department of general dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
c.
Sichuan Provincial Engineering Research Center of Oral Biomaterials, Chengdu 610041, China
d.
National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai 200240, China

taozhang@scu.edu.cn

xcai@scu.edu.cn

Received Date: 23 August 2024
Revised Date: 19 October 2024
Accepted Date: 29 October 2024
Available Online: 30 October 2024

Figures(4)

Osteogenic ability impairment and myelosuppression are common complications of chemotherapy and many chemotherapeutics can affect the skeletal system. Skeletal system protection is necessary for cancer chemotherapy. In this study, osteogenic growth peptide (OGP) and tetrahedral framework nucleic-acid nanostructures (tFNAs) are combined to form a peptide-DNA complex OGP-tFNAs, which aims to combine the positive biological effect on tissue protection and regeneration. The bone marrow protection and bone formation effect of OGP-tFNAs are investigated in chemotherapy-induced myelosuppressive mice. The results show that OGP-tFNAs could reduce the cell damage degree from 5-fluorouracil (5-FU) in vitro and maintained the osteogenic differentiation potential. Furthermore, OGP-tFNAs accelerate bone defect regeneration in myelosuppressive mice. In conclusion, OGP-tFNAs could protect the osteogenic differentiation potential of bone marrow stromal cells (BMSCs) from 5-FU injury and maintain the bone formation ability of myelosuppressive mice suffering from chemotherapy.
- Peptide-DNA nanocomplex,
- Chemotherapy,
- Bone formation,
- Tetrahedral framework nucleic-acid nanostructure,
- Osteogenic growth peptide
1. [1]
  K. Liu, M. Li, Y. Li, et al., Mol. Cancer 23 (2024) 62.
2. [2]
  Q. Gao, J. Feng, W. Liu, et al., Adv. Drug Deliv. Rev. 188 (2022) 114445.
3. [3]
  S. Nezhadi, E. Saadat, S. Handali, F. Dorkoosh, J. Drug. Target. 29 (2021) 185–198. doi: 10.1080/1061186x.2020.1808000
4. [4]
  A.M. Lee, T. Shandala, P.P. Soo, et al., Nutrients 9 (2017) 255. doi: 10.3390/nu9030255
5. [5]
  C. Fan, K.R. Georgiou, H.A. Morris, et al., Breast Cancer Res. Treat. 165 (2017) 41–51. doi: 10.1007/s10549-017-4308-3
6. [6]
  Y. Li, Z. Cai, W. Ma, et al., Bone Res. 12 (2024) 14.
7. [7]
  T. Zhang, T. Tian, Y. Lin, Adv. Mater. 34 (2022) e2107820.
8. [8]
  X. Shao, Z. Hu, H. Su, et al., Cell Prolif. 57 (2024) e13561.
9. [9]
  D. Xiao, T. Chen, T. Zhang, et al., Chin. Chem. Lett. 35 (2024) 108602.
10. [10]
  J. Sun, Y. Gao, Y. Yao, et al., Chem. Eng. J. 487 (2024) 150706.
11. [11]
  T. Zhang, T. Tian, R. Zhou, et al., Nat. Protoc. 15 (2020) 2728–2757. doi: 10.1038/s41596-020-0355-z
12. [12]
  H. Wang, J. Gong, W. Chen, et al., Nano Today 56 (2024) 102252.
13. [13]
  Y. Wen, M. Zhang, Y. Yao, et al., Chin. Chem. Lett. 34 (2023) 107549.
14. [14]
  Y. Ge, Q. Wang, Y. Yao, et al., Adv. Sci. 11 (2024) e2308701.
15. [15]
  Y. Liu, S. Li, S. Lin, et al., Chin. Chem. Lett. 34 (2023) 107987.
16. [16]
  J. Sun, X. Chen, Y. Lin, X. Cai, Cell Prolif. 57 (2024) e13624.
17. [17]
  T. Tian, Y. Li, Y. Lin, Bone Res. 10 (2022) 40. doi: 10.1117/12.2623877
18. [18]
  S. Xu, X. Qin, J. Liang, et al., Cell Prolif. 57 (2024) e13637.
19. [19]
  Y. Li, J. Li, Y. Chang, et al., Chin. Chem. Lett. 35 (2024) 109414.
20. [20]
  S. Lin, Q. Zhang, S. Li, et al., Cell Prolif. 55 (2022) e13279.
21. [21]
  L. Wang, M. Javier, C. Luo, et al., Chin. Chem. Lett. 35 (2024) 109591.
22. [22]
  X. Chen, J. He, Y. Xie, et al., Cell Prolif. 56 (2023) e13424.
23. [23]
  Q. Peng, S. Zhang, Q. Yang, et al., Biomaterials 34 (2013) 8521–8530.
24. [24]
  D. Bargheer, J. Nielsen, G. Gébel, et al., Beilstein J. Nanotechnol. 6 (2015) 36–46. doi: 10.3762/bjnano.6.5
25. [25]
  Z. Jiang, Y. Chu, C. Zhan, Expert Opin. Drug Deliv. 19 (2022) 833–846. doi: 10.1080/17425247.2022.2093854
26. [26]
  F. Guo, S. Luo, L. Wang, et al., Int. J. Biol. Macromol. 256 (2024) 128513.
27. [27]
  J. Bernal-Chanchavac, M. Al-Amin, N. Stephanopoulos, Curr. Top. Med. Chem. 22 (2022) 699–712. doi: 10.2174/1568026621666211215142916
28. [28]
  S. Tarvirdipour, M. Skowicki, C.A. Schoenenberger, C.G. Palivan, Int. J. Mol. Sci. 22 (2021) 9092. doi: 10.3390/ijms22169092
29. [29]
  N. Stephanopoulos, Bioconjug. Chem. 30 (2019) 1915–1922. doi: 10.1021/acs.bioconjchem.9b00259
30. [30]
  T. Macculloch, A. Buchberger, N. Stephanopoulos, Org. Biomol. Chem. 17 (2019) 1668–1682. doi: 10.1039/c8ob02436g
31. [31]
  P. Cai, X. Zhang, M. Wang, et al., ACS Nano 12 (2018) 5078–5084. doi: 10.1021/acsnano.8b03285
32. [32]
  J. Liu, M. Guo, C. Chen, Adv. Drug Deliv. Rev. 186 (2022) 114318. doi: 10.1109/access.2022.3213354
33. [33]
  Q. Xiao, M. Zoulikha, M. Qiu, et al., Adv. Drug Deliv. Rev. 186 (2022) 114356.
34. [34]
  R.K. Mishra, A. Ahmad, A. Vyawahare, et al., Int. J. Biol. Macromol. 175 (2021) 1–18.
35. [35]
  T. Nakayama, K. Kobayashi, T. Kameda, et al., ACS Appl. Mater. Interface. 14 (2022) 32937–32947. doi: 10.1021/acsami.2c08271
36. [36]
  R. Madathiparambil Visalakshan, L.E. González García, M.R. Benzigar, et al., Small 16 (2020) e2000285.
37. [37]
  W. Kim, N.K. Ly, Y. He, et al., Adv. Drug Deliv. Rev. 192 (2022) 114635.
38. [38]
  H. Li, Y. Wang, Q. Tang, et al., Acta Biomater. 129 (2021) 57–72.
39. [39]
  C. Corbo, R. Molinaro, A. Parodi, et al., Nanomedicine 11 (2015) 81–100.
40. [40]
  Y. Yang, J. Yang, J. Zhu, et al., Bioact. Mater. 39 (2024) 191–205.
41. [41]
  Y. Zhang, T. Wang, J. Zhang, et al., Chin. Chem. Lett. 35 (2024) 108619.
42. [42]
  D. Robinson, I. Bab, Z. Nevo, J. Bone Miner Res. 10 (1995) 690–696. doi: 10.1002/jbmr.5650100504
43. [43]
  O. Gurevitch, S. Slavin, A. Muhlrad, et al., Blood 88 (1996) 4719–4724.
44. [44]
  T. Zhang, M. Zhou, D. Xiao, et al., Adv. Sci. 9 (2022) e2202058.
45. [45]
  Z. Lian, T. Ji, J. Mater. Chem. B 8 (2020) 6517–6529. doi: 10.1039/d0tb00713g
46. [46]
  A. Varanko, S. Saha, A. Chilkoti, Adv. Drug Deliv. Rev. 156 (2020) 133–187.
47. [47]
  A. Komin, L.M. Russell, K.A. Hristova, P.C. Searson, Adv. Drug Deliv. Rev. 110-111 (2017) 52–64.
48. [48]
  D. Menon, R. Singh, K.B. Joshi, et al., ChemBioChem 24 (2022) e202200580.
49. [49]
  J.S. Freitag, C. Möser, R. Belay, et al., Nanoscale 15 (2023) 7608–7624. doi: 10.1039/d2nr05429a
50. [50]
  T. Lehto, K. Ezzat, M.J.A. Wood, S. El Andaloussi, Adv. Drug. Deliv. Rev. 106 (2016) 172–182.
51. [51]
  C. Wang, K. Kaur, C. Xu, et al., eLife 13 (2024) RP92885.
52. [52]
  K.R. Georgiou, S.K. Hui, C.J. Xian, Am. J. Stem Cell. 1 (2012) 205–224.
53. [53]
  M.A. Elalfy, P.J. Boland, J.H. Healey, Clin. Orthop. Relat. Res. 477 (2019) 206–216. doi: 10.1097/corr.0000000000000512
54. [54]
  K.R. Georgiou, T.J. King, M.A. Scherer, et al., Bone 50 (2012) 1223–1233.
1. [1]
  Chuyu Huang , Zhishan Liu , Linping Zhao , Zuxiao Chen , Rongrong Zheng , Xiaona Rao , Yuxuan Wei , Xin Chen , Shiying Li . Metal-coordinated oxidative stress amplifier to suppress tumor growth combined with M2 macrophage elimination. Chinese Chemical Letters, 2024, 35(12): 109696-. doi: 10.1016/j.cclet.2024.109696
2. [2]
  Wenbin Zhou , Yafei Gao , Xinyu Feng , Yanqing Zhang , Cong Yang , Lanxi He , Fenghe Zhang , Xiaoguang Li , Qing Li . Biomimetic nanoplatform integrates FRET-enhanced photodynamic therapy and chemotherapy for cascaded revitalization of the tumor immune microenvironment in OSCC. Chinese Chemical Letters, 2025, 36(1): 109763-. doi: 10.1016/j.cclet.2024.109763
3. [3]
  Cheng-Zhe Gao , Hao-Ran Jia , Tian-Yu Wang , Xiao-Yu Zhu , Xiaofeng Han , Fu-Gen Wu . A dual drug-loaded tumor vasculature-targeting liposome for tumor vasculature disruption and hypoxia-enhanced chemotherapy. Chinese Chemical Letters, 2025, 36(1): 109840-. doi: 10.1016/j.cclet.2024.109840
4. [4]
  Tingting Hu , Chao Shen , Xueyan Wang , Fengbo Wu , Zhiyao He . Tumor microenvironment-sensitive polymeric nanoparticles for synergetic chemo-photo therapy. Chinese Chemical Letters, 2024, 35(11): 109562-. doi: 10.1016/j.cclet.2024.109562
5. [5]
  Zhi Li , Shuya Pan , Yuan Tian , Shaowei Liu , Weifeng Wei , Jinlin Wang , Tianfeng Chen , Ling Wang . Selenium nanoparticles enhance the chemotherapeutic efficacy of pemetrexed against non-small cell lung cancer. Chinese Chemical Letters, 2024, 35(12): 110018-. doi: 10.1016/j.cclet.2024.110018
6. [6]
  Du Liu , Yuyan Li , Hankun Zhang , Benhua Wang , Chaoyi Yao , Minhuan Lan , Zhanhong Yang , Xiangzhi Song . Three-in-one erlotinib-modified NIR photosensitizer for fluorescence imaging and synergistic chemo-photodynamic therapy. Chinese Chemical Letters, 2025, 36(2): 109910-. doi: 10.1016/j.cclet.2024.109910
7. [7]
  Ruijianghan Shi , Yujie Zhu , Weitong Lu , Yuhan Shao , Yang Chen , Mi Zhou , Yunfeng Lin , Sirong Shi . Tetrahedral framework nucleic acids enhance osteogenic differentiation and prevent apoptosis for dental follicle stem cell therapy in diabetic bone repair. Chinese Chemical Letters, 2025, 36(5): 110241-. doi: 10.1016/j.cclet.2024.110241
8. [8]
  Yanjing Li , Jiayin Li , Yuqi Chang , Yunfeng Lin , Lei Sui . Tetrahedral framework nucleic acids promote the proliferation and differentiation potential of diabetic bone marrow mesenchymal stem cell. Chinese Chemical Letters, 2024, 35(9): 109414-. doi: 10.1016/j.cclet.2023.109414
9. [9]
  Lihang Wang , Mary Li Javier , Chunshan Luo , Tingsheng Lu , Shudan Yao , Bing Qiu , Yun Wang , Yunfeng Lin . Research advances of tetrahedral framework nucleic acid-based systems in biomedicine. Chinese Chemical Letters, 2024, 35(11): 109591-. doi: 10.1016/j.cclet.2024.109591
10. [10]
  Weijian Zhang , Xianyu Deng , Liying Wang , Jian Wang , Xiuting Guo , Lianggui Huang , Xinyi Wang , Jun Wu , Linjia Jiang . Poly(ferulic acid) nanocarrier enhances chemotherapy sensitivity of acute myeloid leukemia by selectively targeting inflammatory macrophages. Chinese Chemical Letters, 2024, 35(9): 109422-. doi: 10.1016/j.cclet.2023.109422
11. [11]
  Dexuan Xiao , Tianyu Chen , Tianxu Zhang , Sirong Shi , Mei Zhang , Xin Qin , Yunkun Liu , Longjiang Li , Yunfeng Lin . Transdermal treatment for malignant melanoma by aptamer-modified tetrahedral framework nucleic acid delivery of vemurafenib. Chinese Chemical Letters, 2024, 35(4): 108602-. doi: 10.1016/j.cclet.2023.108602
12. [12]
  Shaofeng Gong , Zi-Wei Deng , Chao Wu , Wei-Min He . Stabilized carbon radical-mediated three-component functionalization of amino acid/peptide derivatives. Chinese Chemical Letters, 2025, 36(5): 110936-. doi: 10.1016/j.cclet.2025.110936
13. [13]
  Kai Wang , Yun Wang , Lihang Wang , Zhuhai Li , Xi Yu , Xuanhe You , Diwei Wu , Yueming Song , Jiancheng Zeng , Zongke Zhou , Shishu Huang , Yunfeng Lin . Therapeutic siRNA targeting CC chemokine receptor 2 loaded with tetrahedral framework nucleic acid alleviates neuropathic pain by regulating microglial polarization. Chinese Chemical Letters, 2025, 36(3): 109868-. doi: 10.1016/j.cclet.2024.109868
14. [14]
  Weiyu Chen , Zenghui Li , Chenguang Zhao , Lisha Zha , Junfeng Shi , Dan Yuan . Enzyme-modulate conformational changes in amphiphile peptide for selectively cell delivery. Chinese Chemical Letters, 2024, 35(12): 109628-. doi: 10.1016/j.cclet.2024.109628
15. [15]
  Xiaofang Luo , Ye Wu , Xiaokun Zhang , Min Tang , Feiye Ju , Zuodong Qin , Gregory J Duns , Wei-Dong Zhang , Jiang-Jiang Qin , Xin Luan . Peptide-based strategies for overcoming multidrug-resistance in cancer therapy. Chinese Chemical Letters, 2025, 36(1): 109724-. doi: 10.1016/j.cclet.2024.109724
16. [16]
  Jielin Wang , Han Ye , Bozhuang Zhou , Zhen Pan , Yucai Li , Zhenyuan Wei , Bin Chai , Yizhou Gao , Xiaojian Ye , Jiangming Yu . Biomimetic nanofibrillar/hyaluronic acid hydrogels remodel the neuromodulatory microenvironment for enhanced bone regeneration. Chinese Chemical Letters, 2025, 36(5): 110133-. doi: 10.1016/j.cclet.2024.110133
17. [17]
  Yujie Zhu , Ruijianghan Shi , Weitong Lu , Yang Chen , Yunfeng Lin , Sirong Shi . Tetrahedral framework nucleic acids prevent epithelial-mesenchymal transition-mediated diabetic fibrosis by targeting the Wnt/β-catenin signaling pathway. Chinese Chemical Letters, 2025, 36(5): 110140-. doi: 10.1016/j.cclet.2024.110140
18. [18]
  Rui Wang , He Qi , Haijiao Zheng , Qiong Jia . Light/pH dual-responsive magnetic metal-organic frameworks composites for phosphorylated peptide enrichment. Chinese Chemical Letters, 2024, 35(7): 109215-. doi: 10.1016/j.cclet.2023.109215
19. [19]
  Cheng-Yan Wu , Yi-Nan Gao , Zi-Han Zhang , Rui Liu , Quan Tang , Zhong-Lin Lu . Enhancing self-assembly efficiency of macrocyclic compound into nanotubes by introducing double peptide linkages. Chinese Chemical Letters, 2024, 35(11): 109649-. doi: 10.1016/j.cclet.2024.109649
20. [20]
  Mengmeng Yuan , Xiwen Hu , Na Li , Limin Xu , Mengxi Zhu , Xing Pei , Rui Li , Lu Sun , Yupeng Chen , Fei Yu , Huining He . Kidney targeted delivery of siRNA mediated by peptide-siRNA conjugate for the treatment of acute kidney injury. Chinese Chemical Letters, 2025, 36(6): 110251-. doi: 10.1016/j.cclet.2024.110251

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(20)
HTML views(1)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142